KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Depreciation & Amortization (CF) (2016 - 2025)

Bausch Health Companies' Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $290.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 5.54% year-over-year to $290.0 million; the TTM value through Dec 2025 reached $1.2 billion, down 4.66%, while the annual FY2025 figure was $1.2 billion, 4.66% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $290.0 million at Bausch Health Companies, down from $306.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $404.0 million in Q2 2021 and bottomed at $290.0 million in Q4 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $321.0 million (2024), against an average of $334.2 million.
  • The largest annual shift saw Depreciation & Amortization (CF) fell 16.22% in 2021 before it rose 6.98% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $363.0 million in 2021, then decreased by 0.83% to $360.0 million in 2022, then dropped by 8.61% to $329.0 million in 2023, then decreased by 6.69% to $307.0 million in 2024, then dropped by 5.54% to $290.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Depreciation & Amortization (CF) are $290.0 million (Q4 2025), $306.0 million (Q3 2025), and $307.0 million (Q2 2025).